

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.88191322 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.46548680 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.52669509 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.52669509 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.25577255 |
| 6 | negative T cell selection (GO:0043383) | 5.21552812 |
| 7 | negative thymic T cell selection (GO:0045060) | 5.12259232 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.87680721 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.74750718 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.72993138 |
| 11 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.61909188 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.59203778 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.57424122 |
| 14 | positive T cell selection (GO:0043368) | 4.55568188 |
| 15 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.50709644 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.41262742 |
| 17 | respiratory chain complex IV assembly (GO:0008535) | 4.29679135 |
| 18 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.26281595 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.23629723 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.16461284 |
| 21 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.13617592 |
| 22 | T cell migration (GO:0072678) | 4.12361686 |
| 23 | T cell selection (GO:0045058) | 4.10356283 |
| 24 | negative regulation of T cell mediated immunity (GO:0002710) | 4.00436989 |
| 25 | proteasome assembly (GO:0043248) | 3.97693991 |
| 26 | telomere maintenance via recombination (GO:0000722) | 3.97422283 |
| 27 | thymic T cell selection (GO:0045061) | 3.96967654 |
| 28 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.96019474 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.89504837 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.88691681 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.88691681 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 3.88691681 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.88691681 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.88691681 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.88691681 |
| 36 | protein deneddylation (GO:0000338) | 3.88303503 |
| 37 | cellular extravasation (GO:0045123) | 3.86645101 |
| 38 | response to interleukin-15 (GO:0070672) | 3.82276196 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.82097678 |
| 40 | DNA strand elongation (GO:0022616) | 3.81761812 |
| 41 | cytochrome complex assembly (GO:0017004) | 3.81437294 |
| 42 | cullin deneddylation (GO:0010388) | 3.81267196 |
| 43 | activated T cell proliferation (GO:0050798) | 3.77697453 |
| 44 | tolerance induction (GO:0002507) | 3.71688241 |
| 45 | leukocyte aggregation (GO:0070486) | 3.71620256 |
| 46 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.70564100 |
| 47 | termination of RNA polymerase III transcription (GO:0006386) | 3.70564100 |
| 48 | ribosomal small subunit assembly (GO:0000028) | 3.70557674 |
| 49 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.70207368 |
| 50 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.70207368 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 3.64554874 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 3.62654242 |
| 53 | DNA replication initiation (GO:0006270) | 3.62030756 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 3.59590467 |
| 55 | interferon-gamma production (GO:0032609) | 3.59234122 |
| 56 | pseudouridine synthesis (GO:0001522) | 3.56532758 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 3.56102700 |
| 58 | protein complex biogenesis (GO:0070271) | 3.55381103 |
| 59 | positive regulation of granulocyte differentiation (GO:0030854) | 3.54893702 |
| 60 | regulation of mitochondrial translation (GO:0070129) | 3.54522085 |
| 61 | iron-sulfur cluster assembly (GO:0016226) | 3.53194751 |
| 62 | metallo-sulfur cluster assembly (GO:0031163) | 3.53194751 |
| 63 | regulation of B cell differentiation (GO:0045577) | 3.46343323 |
| 64 | mitotic recombination (GO:0006312) | 3.41580176 |
| 65 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.39759405 |
| 66 | amino acid salvage (GO:0043102) | 3.39112300 |
| 67 | L-methionine salvage (GO:0071267) | 3.39112300 |
| 68 | L-methionine biosynthetic process (GO:0071265) | 3.39112300 |
| 69 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.38334934 |
| 70 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.38074748 |
| 71 | regulation of tolerance induction (GO:0002643) | 3.35614435 |
| 72 | telomere maintenance via telomere lengthening (GO:0010833) | 3.33813609 |
| 73 | detection of other organism (GO:0098543) | 3.33712980 |
| 74 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.32091365 |
| 75 | NADH dehydrogenase complex assembly (GO:0010257) | 3.32091365 |
| 76 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.32091365 |
| 77 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.30518522 |
| 78 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.30518522 |
| 79 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29972325 |
| 80 | cellular response to type I interferon (GO:0071357) | 3.29753801 |
| 81 | type I interferon signaling pathway (GO:0060337) | 3.29753801 |
| 82 | response to type I interferon (GO:0034340) | 3.28468659 |
| 83 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.28357565 |
| 84 | rRNA modification (GO:0000154) | 3.27950668 |
| 85 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.27009452 |
| 86 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.26297428 |
| 87 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.25410330 |
| 88 | response to muramyl dipeptide (GO:0032495) | 3.25302800 |
| 89 | DNA replication checkpoint (GO:0000076) | 3.21499104 |
| 90 | GDP-mannose metabolic process (GO:0019673) | 3.20802192 |
| 91 | tRNA methylation (GO:0030488) | 3.19572214 |
| 92 | signal peptide processing (GO:0006465) | 3.14579554 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 3.14501139 |
| 94 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.14086841 |
| 95 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.14086841 |
| 96 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.14086841 |
| 97 | response to peptidoglycan (GO:0032494) | 3.14079092 |
| 98 | detection of bacterium (GO:0016045) | 3.13303381 |
| 99 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.12692756 |
| 100 | mannosylation (GO:0097502) | 3.12625132 |
| 101 | 7-methylguanosine mRNA capping (GO:0006370) | 3.11965370 |
| 102 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11368589 |
| 103 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.11164466 |
| 104 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.10311857 |
| 105 | cellular response to ethanol (GO:0071361) | 3.10238610 |
| 106 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.10216922 |
| 107 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.09369963 |
| 108 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.08924367 |
| 109 | detection of molecule of bacterial origin (GO:0032490) | 3.07164043 |
| 110 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.06512305 |
| 111 | nucleobase biosynthetic process (GO:0046112) | 3.06482227 |
| 112 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.06098542 |
| 113 | negative regulation of ligase activity (GO:0051352) | 3.06098542 |
| 114 | RNA capping (GO:0036260) | 3.05965426 |
| 115 | 7-methylguanosine RNA capping (GO:0009452) | 3.05965426 |
| 116 | microglial cell activation (GO:0001774) | 3.05627729 |
| 117 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.05585798 |
| 118 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.05585798 |
| 119 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.04887106 |
| 120 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.03702756 |
| 121 | ribosome biogenesis (GO:0042254) | 3.03464986 |
| 122 | histone H2A acetylation (GO:0043968) | 3.02759957 |
| 123 | myeloid cell activation involved in immune response (GO:0002275) | 3.02675118 |
| 124 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.02017014 |
| 125 | positive regulation of tolerance induction (GO:0002645) | 3.01903837 |
| 126 | rRNA methylation (GO:0031167) | 3.01318390 |
| 127 | purine nucleobase biosynthetic process (GO:0009113) | 3.00444647 |
| 128 | neutrophil activation involved in immune response (GO:0002283) | 2.99956563 |
| 129 | T cell receptor signaling pathway (GO:0050852) | 2.99060638 |
| 130 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.98777205 |
| 131 | detection of external biotic stimulus (GO:0098581) | 2.97217681 |
| 132 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.95812016 |
| 133 | T cell costimulation (GO:0031295) | 2.95619303 |
| 134 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.95613860 |
| 135 | presynaptic membrane assembly (GO:0097105) | 2.94938990 |
| 136 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.94825151 |
| 137 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.94060165 |
| 138 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.94060165 |
| 139 | NIK/NF-kappaB signaling (GO:0038061) | 2.93321411 |
| 140 | lymphocyte costimulation (GO:0031294) | 2.91446803 |
| 141 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.91394382 |
| 142 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.91303913 |
| 143 | mast cell activation (GO:0045576) | 2.89108223 |
| 144 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88041925 |
| 145 | platelet dense granule organization (GO:0060155) | 2.87754047 |
| 146 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.87718655 |
| 147 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.87625061 |
| 148 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.86495120 |
| 149 | positive regulation of interleukin-2 production (GO:0032743) | 2.84875702 |
| 150 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.84788634 |
| 151 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.84579371 |
| 152 | positive regulation of mast cell activation (GO:0033005) | 2.84318226 |
| 153 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.83879473 |
| 154 | T cell proliferation (GO:0042098) | 2.83648592 |
| 155 | regulation of regulatory T cell differentiation (GO:0045589) | 2.82716760 |
| 156 | maturation of SSU-rRNA (GO:0030490) | 2.82710826 |
| 157 | defense response to protozoan (GO:0042832) | 2.82286366 |
| 158 | regulation of antigen processing and presentation (GO:0002577) | 2.81958267 |
| 159 | maturation of 5.8S rRNA (GO:0000460) | 2.81807117 |
| 160 | myeloid dendritic cell activation (GO:0001773) | 2.81320820 |
| 161 | positive regulation of antigen processing and presentation (GO:0002579) | 2.81100041 |
| 162 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.80779555 |
| 163 | tRNA processing (GO:0008033) | 2.78970877 |
| 164 | intra-S DNA damage checkpoint (GO:0031573) | 2.78394352 |
| 165 | germinal center formation (GO:0002467) | 2.78287708 |
| 166 | CENP-A containing nucleosome assembly (GO:0034080) | 2.76895166 |
| 167 | positive regulation of B cell mediated immunity (GO:0002714) | 2.76762269 |
| 168 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.76762269 |
| 169 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.76454183 |
| 170 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.76454183 |
| 171 | B cell homeostasis (GO:0001782) | 2.76223884 |
| 172 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.75450161 |
| 173 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.74821744 |
| 174 | regulation of alpha-beta T cell activation (GO:0046634) | 2.74590887 |
| 175 | tRNA modification (GO:0006400) | 2.73690285 |
| 176 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.73616700 |
| 177 | postsynaptic membrane organization (GO:0001941) | 2.73245977 |
| 178 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.73185409 |
| 179 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.73086326 |
| 180 | response to host immune response (GO:0052572) | 2.72886652 |
| 181 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.72886652 |
| 182 | cellular component biogenesis (GO:0044085) | 2.71201312 |
| 183 | peptidyl-histidine modification (GO:0018202) | 2.70217622 |
| 184 | methionine biosynthetic process (GO:0009086) | 2.69873933 |
| 185 | RNA methylation (GO:0001510) | 2.69649297 |
| 186 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.69397307 |
| 187 | positive regulation of isotype switching (GO:0045830) | 2.69330913 |
| 188 | positive regulation of humoral immune response (GO:0002922) | 2.69199562 |
| 189 | macrophage activation (GO:0042116) | 2.68695815 |
| 190 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.67974637 |
| 191 | ribosome assembly (GO:0042255) | 2.67591194 |
| 192 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.67319682 |
| 193 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.67157993 |
| 194 | chaperone-mediated protein transport (GO:0072321) | 2.66864421 |
| 195 | response to interferon-beta (GO:0035456) | 2.66351988 |
| 196 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.66341825 |
| 197 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.64721997 |
| 198 | chromatin remodeling at centromere (GO:0031055) | 2.62901176 |
| 199 | positive regulation of protein homodimerization activity (GO:0090073) | 2.62739489 |
| 200 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.62171605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.15197757 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.70343762 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.70342266 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.28925628 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.06537828 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.03561871 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.86152994 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.58729537 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.58050684 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.55306881 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.50663320 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.45035582 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.39164235 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.37573931 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.33814490 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.31862924 |
| 17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.20099457 |
| 18 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17022206 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.15498227 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.13427866 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.02308733 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.89652483 |
| 23 | * MYB_26560356_Chip-Seq_TH2_Human | 2.82536962 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.75332230 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.74680134 |
| 26 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67428118 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.65682773 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.59187535 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.52640745 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.51747592 |
| 31 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.48083709 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47957727 |
| 33 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.45826471 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.43822294 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.36533344 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.35836786 |
| 37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.32905188 |
| 38 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.30564655 |
| 39 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24619467 |
| 40 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.22468479 |
| 41 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.21770425 |
| 42 | * MYB_26560356_Chip-Seq_TH1_Human | 2.19505499 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12742885 |
| 44 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.12498959 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 2.11044872 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.10107590 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08860649 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.08501511 |
| 49 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.07897016 |
| 50 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.07748083 |
| 51 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.07704054 |
| 52 | * MAF_26560356_Chip-Seq_TH1_Human | 2.06686219 |
| 53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06080694 |
| 54 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.03946117 |
| 55 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.03512560 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02652170 |
| 57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.00932737 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.96122196 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94708907 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.94333745 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89383674 |
| 62 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.88879731 |
| 63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82841957 |
| 64 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81697045 |
| 65 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80471123 |
| 66 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.80111878 |
| 67 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.78199783 |
| 68 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.77810479 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 1.74231426 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71525065 |
| 71 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71064293 |
| 72 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.69936681 |
| 73 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.69348503 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69201258 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68734645 |
| 76 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.66532258 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64520939 |
| 78 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64452307 |
| 79 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63490203 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63399249 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60187366 |
| 82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60006313 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.59903457 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59878121 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.57897318 |
| 86 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.57534003 |
| 87 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.56972181 |
| 88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.54619567 |
| 89 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53645645 |
| 90 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.50782191 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48705734 |
| 92 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47448800 |
| 93 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.45251968 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 1.42459833 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41852657 |
| 96 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41833471 |
| 97 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41461836 |
| 98 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39156325 |
| 99 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37239668 |
| 100 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.34104118 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33058025 |
| 102 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.32184726 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31322169 |
| 104 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30726992 |
| 105 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.29121382 |
| 106 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.28571528 |
| 107 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28534456 |
| 108 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26530109 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25534793 |
| 110 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23573372 |
| 111 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23468532 |
| 112 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22366692 |
| 113 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21075766 |
| 114 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.18538979 |
| 115 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.16969911 |
| 116 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16610400 |
| 117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16109651 |
| 118 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13578523 |
| 119 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13328431 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12652076 |
| 121 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12376313 |
| 122 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.09440626 |
| 123 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.09327615 |
| 124 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07318538 |
| 125 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06795504 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05915922 |
| 127 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05429475 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05279533 |
| 129 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04216912 |
| 130 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03152262 |
| 131 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02186926 |
| 132 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00488232 |
| 133 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.00004581 |
| 134 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96046706 |
| 135 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95120887 |
| 136 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.95093090 |
| 137 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94568639 |
| 138 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94547616 |
| 139 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93933475 |
| 140 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.93773105 |
| 141 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.91551838 |
| 142 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90744942 |
| 143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90586329 |
| 144 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89841826 |
| 145 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86937523 |
| 146 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.86911209 |
| 147 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86855932 |
| 148 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.85914904 |
| 149 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.85881512 |
| 150 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85368685 |
| 151 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85241017 |
| 152 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82623030 |
| 153 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82345336 |
| 154 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82115485 |
| 155 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.81132148 |
| 156 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.81130396 |
| 157 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80136031 |
| 158 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79500867 |
| 159 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.79216264 |
| 160 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.74622143 |
| 161 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.72451550 |
| 162 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.71519584 |
| 163 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71204407 |
| 164 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.70564079 |
| 165 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.70198625 |
| 166 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.69368877 |
| 167 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.67099106 |
| 168 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.66909003 |
| 169 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.66627470 |
| 170 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65802514 |
| 171 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.64490694 |
| 172 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.63739911 |
| 173 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.63122943 |
| 174 | GATA3_26560356_Chip-Seq_TH1_Human | 0.62145276 |
| 175 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.62041826 |
| 176 | TP53_16413492_ChIP-PET_HCT116_Human | 0.59252217 |
| 177 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58949566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006292_abnormal_olfactory_placode | 3.31603764 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.11637665 |
| 3 | MP0001188_hyperpigmentation | 3.11393366 |
| 4 | MP0008058_abnormal_DNA_repair | 3.04597059 |
| 5 | MP0005075_abnormal_melanosome_morpholog | 2.91450048 |
| 6 | MP0005387_immune_system_phenotype | 2.88056071 |
| 7 | MP0001790_abnormal_immune_system | 2.88056071 |
| 8 | MP0001986_abnormal_taste_sensitivity | 2.85819286 |
| 9 | MP0003303_peritoneal_inflammation | 2.84578178 |
| 10 | MP0000015_abnormal_ear_pigmentation | 2.75429946 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.74902458 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.66981407 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.63290649 |
| 14 | MP0006082_CNS_inflammation | 2.61056676 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.58532452 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.31538972 |
| 17 | MP0005174_abnormal_tail_pigmentation | 2.31386901 |
| 18 | MP0004147_increased_porphyrin_level | 2.26931972 |
| 19 | MP0002095_abnormal_skin_pigmentation | 2.20511682 |
| 20 | MP0008260_abnormal_autophagy | 2.14349066 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.10222143 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.08242311 |
| 23 | MP0002876_abnormal_thyroid_physiology | 2.06862299 |
| 24 | MP0002405_respiratory_system_inflammati | 2.05585658 |
| 25 | MP0008007_abnormal_cellular_replicative | 2.03765412 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.92912583 |
| 27 | MP0003111_abnormal_nucleus_morphology | 1.91271897 |
| 28 | MP0003724_increased_susceptibility_to | 1.83618713 |
| 29 | MP0004957_abnormal_blastocyst_morpholog | 1.83016242 |
| 30 | MP0004947_skin_inflammation | 1.82028813 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.78684513 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.78057721 |
| 33 | MP0003077_abnormal_cell_cycle | 1.77397111 |
| 34 | MP0009379_abnormal_foot_pigmentation | 1.76095267 |
| 35 | MP0003787_abnormal_imprinting | 1.75757377 |
| 36 | MP0008057_abnormal_DNA_replication | 1.75477972 |
| 37 | MP0009697_abnormal_copulation | 1.73157399 |
| 38 | MP0005310_abnormal_salivary_gland | 1.72782322 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.72250416 |
| 40 | MP0003880_abnormal_central_pattern | 1.70709286 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.67374000 |
| 42 | MP0003786_premature_aging | 1.63327836 |
| 43 | MP0000681_abnormal_thyroid_gland | 1.62993751 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.58987349 |
| 45 | MP0003690_abnormal_glial_cell | 1.58525254 |
| 46 | MP0005671_abnormal_response_to | 1.58305309 |
| 47 | MP0002009_preneoplasia | 1.57313713 |
| 48 | MP0000490_abnormal_crypts_of | 1.56647885 |
| 49 | MP0000372_irregular_coat_pigmentation | 1.56404384 |
| 50 | MP0002736_abnormal_nociception_after | 1.54810701 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.53741691 |
| 52 | MP0009785_altered_susceptibility_to | 1.52963912 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.52062843 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 1.48411613 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.46304048 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.46304048 |
| 57 | MP0002006_tumorigenesis | 1.44484718 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.43136447 |
| 59 | MP0003879_abnormal_hair_cell | 1.42629761 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.42004473 |
| 61 | MP0002132_abnormal_respiratory_system | 1.40167509 |
| 62 | MP0000604_amyloidosis | 1.39897976 |
| 63 | MP0004381_abnormal_hair_follicle | 1.38321210 |
| 64 | MP0003828_pulmonary_edema | 1.36757772 |
| 65 | MP0003186_abnormal_redox_activity | 1.35867882 |
| 66 | MP0001764_abnormal_homeostasis | 1.34663936 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.33886416 |
| 68 | MP0009278_abnormal_bone_marrow | 1.33470465 |
| 69 | MP0005171_absent_coat_pigmentation | 1.32882341 |
| 70 | MP0001968_abnormal_touch/_nociception | 1.32735189 |
| 71 | MP0003763_abnormal_thymus_physiology | 1.30566185 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.29696305 |
| 73 | MP0002160_abnormal_reproductive_system | 1.28182477 |
| 74 | MP0003091_abnormal_cell_migration | 1.27400523 |
| 75 | MP0001851_eye_inflammation | 1.27302321 |
| 76 | MP0008932_abnormal_embryonic_tissue | 1.26156471 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.26043447 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.25035633 |
| 79 | MP0008469_abnormal_protein_level | 1.24032044 |
| 80 | MP0004142_abnormal_muscle_tone | 1.22719548 |
| 81 | MP0002398_abnormal_bone_marrow | 1.22309263 |
| 82 | MP0001873_stomach_inflammation | 1.22033751 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 1.21745216 |
| 84 | MP0005451_abnormal_body_composition | 1.21565734 |
| 85 | MP0006035_abnormal_mitochondrial_morpho | 1.21287161 |
| 86 | MP0009764_decreased_sensitivity_to | 1.19272333 |
| 87 | MP0001853_heart_inflammation | 1.17426552 |
| 88 | MP0004883_abnormal_blood_vessel | 1.15812122 |
| 89 | MP0002735_abnormal_chemical_nociception | 1.15661718 |
| 90 | MP0002148_abnormal_hypersensitivity_rea | 1.15123401 |
| 91 | MP0003045_fibrosis | 1.14468765 |
| 92 | MP0003448_altered_tumor_morphology | 1.13882445 |
| 93 | MP0000858_altered_metastatic_potential | 1.13408811 |
| 94 | MP0010386_abnormal_urinary_bladder | 1.08283453 |
| 95 | MP0002933_joint_inflammation | 1.08216528 |
| 96 | MP0000689_abnormal_spleen_morphology | 1.07930894 |
| 97 | MP0000920_abnormal_myelination | 1.06711055 |
| 98 | MP0002420_abnormal_adaptive_immunity | 1.04854476 |
| 99 | MP0003866_abnormal_defecation | 1.03369199 |
| 100 | MP0001819_abnormal_immune_cell | 1.02025633 |
| 101 | MP0003075_altered_response_to | 1.01197020 |
| 102 | MP0005025_abnormal_response_to | 1.00779224 |
| 103 | MP0002751_abnormal_autonomic_nervous | 0.99737930 |
| 104 | MP0001905_abnormal_dopamine_level | 0.99388826 |
| 105 | MP0004510_myositis | 0.99146296 |
| 106 | MP0006054_spinal_hemorrhage | 0.98125058 |
| 107 | MP0001529_abnormal_vocalization | 0.98100514 |
| 108 | MP0009745_abnormal_behavioral_response | 0.98048374 |
| 109 | MP0001186_pigmentation_phenotype | 0.98017309 |
| 110 | MP0000716_abnormal_immune_system | 0.97357405 |
| 111 | MP0002429_abnormal_blood_cell | 0.97212760 |
| 112 | MP0002722_abnormal_immune_system | 0.97009608 |
| 113 | MP0005389_reproductive_system_phenotype | 0.96474959 |
| 114 | MP0002723_abnormal_immune_serum | 0.95163014 |
| 115 | MP0002419_abnormal_innate_immunity | 0.94666968 |
| 116 | MP0002019_abnormal_tumor_incidence | 0.94569364 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.93883536 |
| 118 | MP0005166_decreased_susceptibility_to | 0.93521638 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.93212043 |
| 120 | MP0005000_abnormal_immune_tolerance | 0.91939527 |
| 121 | MP0000358_abnormal_cell_content/ | 0.91474940 |
| 122 | MP0003646_muscle_fatigue | 0.90975263 |
| 123 | MP0002075_abnormal_coat/hair_pigmentati | 0.90261828 |
| 124 | MP0003279_aneurysm | 0.89080810 |
| 125 | MP0000343_altered_response_to | 0.87901671 |
| 126 | MP0000313_abnormal_cell_death | 0.87683410 |
| 127 | MP0005164_abnormal_response_to | 0.86550106 |
| 128 | MP0002638_abnormal_pupillary_reflex | 0.86109676 |
| 129 | MP0001919_abnormal_reproductive_system | 0.85919939 |
| 130 | MP0009840_abnormal_foam_cell | 0.85713509 |
| 131 | MP0005645_abnormal_hypothalamus_physiol | 0.84997661 |
| 132 | MP0005409_darkened_coat_color | 0.84180390 |
| 133 | MP0009763_increased_sensitivity_to | 0.83707822 |
| 134 | MP0002452_abnormal_antigen_presenting | 0.83583981 |
| 135 | MP0003718_maternal_effect | 0.83261594 |
| 136 | MP0000249_abnormal_blood_vessel | 0.80733044 |
| 137 | MP0003436_decreased_susceptibility_to | 0.80533387 |
| 138 | MP0000685_abnormal_immune_system | 0.80496474 |
| 139 | MP0002693_abnormal_pancreas_physiology | 0.79725001 |
| 140 | MP0001958_emphysema | 0.79542453 |
| 141 | MP0002272_abnormal_nervous_system | 0.77368876 |
| 142 | MP0002210_abnormal_sex_determination | 0.77242234 |
| 143 | MP0003123_paternal_imprinting | 0.77170515 |
| 144 | MP0006276_abnormal_autonomic_nervous | 0.75209282 |
| 145 | MP0002138_abnormal_hepatobiliary_system | 0.74972162 |
| 146 | MP0000703_abnormal_thymus_morphology | 0.74811041 |
| 147 | MP0000371_diluted_coat_color | 0.74731067 |
| 148 | MP0001800_abnormal_humoral_immune | 0.73540558 |
| 149 | MP0005464_abnormal_platelet_physiology | 0.72973536 |
| 150 | MP0003795_abnormal_bone_structure | 0.69628391 |
| 151 | MP0005390_skeleton_phenotype | 0.68382665 |
| 152 | MP0009115_abnormal_fat_cell | 0.67913065 |
| 153 | MP0004130_abnormal_muscle_cell | 0.66819623 |
| 154 | MP0001663_abnormal_digestive_system | 0.66233450 |
| 155 | MP0008004_abnormal_stomach_pH | 0.63063920 |
| 156 | MP0009765_abnormal_xenobiotic_induced | 0.60127077 |
| 157 | MP0003329_amyloid_beta_deposits | 0.56629196 |
| 158 | MP0005167_abnormal_blood-brain_barrier | 0.54814653 |
| 159 | MP0002332_abnormal_exercise_endurance | 0.53704870 |
| 160 | MP0008874_decreased_physiological_sensi | 0.53630921 |
| 161 | MP0005621_abnormal_cell_physiology | 0.47196171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.22558016 |
| 2 | Type I transferrin isoform profile (HP:0003642) | 4.98669117 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.89674361 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.87271078 |
| 5 | Abnormality of T cell number (HP:0011839) | 4.82085746 |
| 6 | Aplastic anemia (HP:0001915) | 4.74221840 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.51139642 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.32416321 |
| 9 | Recurrent cutaneous fungal infections (HP:0011370) | 4.32195002 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.32195002 |
| 11 | Reduced antithrombin III activity (HP:0001976) | 4.10193215 |
| 12 | Stomatitis (HP:0010280) | 4.00731312 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.98947070 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.89387507 |
| 15 | Recurrent viral infections (HP:0004429) | 3.89116433 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.87475998 |
| 17 | Optic neuritis (HP:0100653) | 3.87475998 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.85908094 |
| 19 | Abnormal protein glycosylation (HP:0012346) | 3.77755933 |
| 20 | Abnormal glycosylation (HP:0012345) | 3.77755933 |
| 21 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.77755933 |
| 22 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.77755933 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.75068443 |
| 24 | Recurrent skin infections (HP:0001581) | 3.71477961 |
| 25 | Orchitis (HP:0100796) | 3.69075674 |
| 26 | Spontaneous hematomas (HP:0007420) | 3.67811598 |
| 27 | Abnormality of T cells (HP:0002843) | 3.59135293 |
| 28 | Meningitis (HP:0001287) | 3.56935544 |
| 29 | Hepatic necrosis (HP:0002605) | 3.40286525 |
| 30 | Vasculitis (HP:0002633) | 3.39760817 |
| 31 | Birth length less than 3rd percentile (HP:0003561) | 3.39489250 |
| 32 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.38766920 |
| 33 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.38766920 |
| 34 | Mitochondrial inheritance (HP:0001427) | 3.31994920 |
| 35 | Pulmonary infiltrates (HP:0002113) | 3.30419191 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.23557279 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 3.22013277 |
| 38 | Pustule (HP:0200039) | 3.16688978 |
| 39 | Hemoptysis (HP:0002105) | 3.13189554 |
| 40 | Type 2 muscle fiber atrophy (HP:0003554) | 3.12228945 |
| 41 | Increased CSF lactate (HP:0002490) | 3.12192402 |
| 42 | Microvesicular hepatic steatosis (HP:0001414) | 3.09491508 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 3.07717909 |
| 44 | Encephalitis (HP:0002383) | 3.02995035 |
| 45 | Colitis (HP:0002583) | 3.00671295 |
| 46 | Autoimmune hemolytic anemia (HP:0001890) | 2.99383759 |
| 47 | Abnormal number of erythroid precursors (HP:0012131) | 2.97624397 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.96798725 |
| 49 | Hypothermia (HP:0002045) | 2.91201163 |
| 50 | Agammaglobulinemia (HP:0004432) | 2.90966131 |
| 51 | Obstructive lung disease (HP:0006536) | 2.89731689 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89731689 |
| 53 | Recurrent bronchitis (HP:0002837) | 2.89607374 |
| 54 | Leukocytosis (HP:0001974) | 2.88445974 |
| 55 | Increased serum lactate (HP:0002151) | 2.88248767 |
| 56 | Pancreatic fibrosis (HP:0100732) | 2.85951959 |
| 57 | Thrombocytosis (HP:0001894) | 2.84553870 |
| 58 | Abnormality of alanine metabolism (HP:0010916) | 2.84271220 |
| 59 | Hyperalaninemia (HP:0003348) | 2.84271220 |
| 60 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.84271220 |
| 61 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.82606063 |
| 62 | IgM deficiency (HP:0002850) | 2.81820919 |
| 63 | Gingivitis (HP:0000230) | 2.81624280 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.78763935 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.72178337 |
| 66 | Muscle fiber atrophy (HP:0100295) | 2.71775550 |
| 67 | Abnormal hair whorl (HP:0010721) | 2.69826063 |
| 68 | Chest pain (HP:0100749) | 2.69087046 |
| 69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.69067918 |
| 70 | Abnormality of glycolipid metabolism (HP:0010969) | 2.69067918 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.69067918 |
| 72 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.67959570 |
| 73 | Agnosia (HP:0010524) | 2.64219845 |
| 74 | True hermaphroditism (HP:0010459) | 2.62657252 |
| 75 | Keratoconjunctivitis sicca (HP:0001097) | 2.62579308 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.61090596 |
| 77 | Spondylolisthesis (HP:0003302) | 2.60799183 |
| 78 | Lymphopenia (HP:0001888) | 2.59589766 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.58944641 |
| 80 | Granulocytopenia (HP:0001913) | 2.57790100 |
| 81 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.57444770 |
| 82 | IgG deficiency (HP:0004315) | 2.57075813 |
| 83 | Severe visual impairment (HP:0001141) | 2.55788256 |
| 84 | Eosinophilia (HP:0001880) | 2.55356926 |
| 85 | Lactic acidosis (HP:0003128) | 2.54189397 |
| 86 | Thyroid-stimulating hormone excess (HP:0002925) | 2.51217294 |
| 87 | Epistaxis (HP:0000421) | 2.50370496 |
| 88 | Chronic diarrhea (HP:0002028) | 2.49963347 |
| 89 | Hematochezia (HP:0002573) | 2.49629024 |
| 90 | Arterial thrombosis (HP:0004420) | 2.49385747 |
| 91 | Pancreatic cysts (HP:0001737) | 2.49238715 |
| 92 | Pancytopenia (HP:0001876) | 2.48483002 |
| 93 | Abnormality of eosinophils (HP:0001879) | 2.48433658 |
| 94 | Pulmonary embolism (HP:0002204) | 2.47901539 |
| 95 | Cellulitis (HP:0100658) | 2.45193343 |
| 96 | 3-Methylglutaconic aciduria (HP:0003535) | 2.45104320 |
| 97 | Keratoconjunctivitis (HP:0001096) | 2.43909924 |
| 98 | Increased cerebral lipofuscin (HP:0011813) | 2.42653475 |
| 99 | Gingival bleeding (HP:0000225) | 2.42608101 |
| 100 | Focal motor seizures (HP:0011153) | 2.42481801 |
| 101 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42199284 |
| 102 | Slow saccadic eye movements (HP:0000514) | 2.41979995 |
| 103 | Severe combined immunodeficiency (HP:0004430) | 2.41409950 |
| 104 | Acute encephalopathy (HP:0006846) | 2.39175173 |
| 105 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.38047533 |
| 106 | Poor suck (HP:0002033) | 2.37457700 |
| 107 | Reticulocytopenia (HP:0001896) | 2.35541835 |
| 108 | Dysostosis multiplex (HP:0000943) | 2.33596797 |
| 109 | Progressive macrocephaly (HP:0004481) | 2.30911222 |
| 110 | Oral leukoplakia (HP:0002745) | 2.29954341 |
| 111 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.29098267 |
| 112 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.28673753 |
| 113 | Prolonged bleeding time (HP:0003010) | 2.27830040 |
| 114 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27516373 |
| 115 | Increased hepatocellular lipid droplets (HP:0006565) | 2.25040440 |
| 116 | Abnormality of the prostate (HP:0008775) | 2.24992018 |
| 117 | Microretrognathia (HP:0000308) | 2.23981744 |
| 118 | Exertional dyspnea (HP:0002875) | 2.23308583 |
| 119 | Viral hepatitis (HP:0006562) | 2.21126979 |
| 120 | IgA deficiency (HP:0002720) | 2.20877624 |
| 121 | Cortical visual impairment (HP:0100704) | 2.20182805 |
| 122 | Exercise intolerance (HP:0003546) | 2.19442315 |
| 123 | Abnormal spermatogenesis (HP:0008669) | 2.19242218 |
| 124 | Increased IgE level (HP:0003212) | 2.18110309 |
| 125 | Papilledema (HP:0001085) | 2.17654126 |
| 126 | Gastrointestinal stroma tumor (HP:0100723) | 2.17217051 |
| 127 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.17002729 |
| 128 | Nephrogenic diabetes insipidus (HP:0009806) | 2.16424304 |
| 129 | Increased IgM level (HP:0003496) | 2.15916414 |
| 130 | Verrucae (HP:0200043) | 2.14700945 |
| 131 | Papilloma (HP:0012740) | 2.14700945 |
| 132 | Vacuolated lymphocytes (HP:0001922) | 2.14292998 |
| 133 | Renal Fanconi syndrome (HP:0001994) | 2.14062315 |
| 134 | Protruding tongue (HP:0010808) | 2.13806536 |
| 135 | Epileptic encephalopathy (HP:0200134) | 2.13188845 |
| 136 | Restrictive lung disease (HP:0002091) | 2.12261284 |
| 137 | Combined immunodeficiency (HP:0005387) | 2.11532775 |
| 138 | Osteomyelitis (HP:0002754) | 2.11200310 |
| 139 | Conjunctival telangiectasia (HP:0000524) | 2.11198224 |
| 140 | Myositis (HP:0100614) | 2.11025629 |
| 141 | Hypoplasia of the thymus (HP:0000778) | 2.10370580 |
| 142 | Loss of speech (HP:0002371) | 2.09491412 |
| 143 | Urticaria (HP:0001025) | 2.09382612 |
| 144 | Abnormality of the preputium (HP:0100587) | 2.09195932 |
| 145 | Medial flaring of the eyebrow (HP:0010747) | 2.09092071 |
| 146 | Increased intramyocellular lipid droplets (HP:0012240) | 2.08601632 |
| 147 | Abnormality of the pleura (HP:0002103) | 2.08230272 |
| 148 | Chromsome breakage (HP:0040012) | 2.07831707 |
| 149 | Abnormality of the columella (HP:0009929) | 2.04881718 |
| 150 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04828096 |
| 151 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.04357807 |
| 152 | Myelodysplasia (HP:0002863) | 2.03450697 |
| 153 | Abnormality of the fingertips (HP:0001211) | 2.03040974 |
| 154 | Abnormality of DNA repair (HP:0003254) | 2.02585209 |
| 155 | Bone marrow hypocellularity (HP:0005528) | 2.01243591 |
| 156 | Glomerulopathy (HP:0100820) | 2.00584722 |
| 157 | Hypergammaglobulinemia (HP:0010702) | 1.97659174 |
| 158 | Gangrene (HP:0100758) | 1.96288451 |
| 159 | Fatigue (HP:0012378) | 1.96272766 |
| 160 | Joint swelling (HP:0001386) | 1.96031861 |
| 161 | Polyneuropathy (HP:0001271) | 1.94941437 |
| 162 | Anorexia (HP:0002039) | 1.94295911 |
| 163 | Amaurosis fugax (HP:0100576) | 1.93388723 |
| 164 | 11 pairs of ribs (HP:0000878) | 1.91448472 |
| 165 | Congenital primary aphakia (HP:0007707) | 1.90815753 |
| 166 | Respiratory difficulties (HP:0002880) | 1.88980648 |
| 167 | Lipid accumulation in hepatocytes (HP:0006561) | 1.87617064 |
| 168 | Pallor (HP:0000980) | 1.86779342 |
| 169 | Premature graying of hair (HP:0002216) | 1.86635907 |
| 170 | Unsteady gait (HP:0002317) | 1.84151360 |
| 171 | Pulmonary fibrosis (HP:0002206) | 1.83785317 |
| 172 | Increased CSF protein (HP:0002922) | 1.83687863 |
| 173 | Acute lymphatic leukemia (HP:0006721) | 1.83423082 |
| 174 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.82880443 |
| 175 | Thyroiditis (HP:0100646) | 1.82295237 |
| 176 | Hyperventilation (HP:0002883) | 1.82075782 |
| 177 | Petechiae (HP:0000967) | 1.81670850 |
| 178 | Breast hypoplasia (HP:0003187) | 1.81265726 |
| 179 | Respiratory failure (HP:0002878) | 1.79233139 |
| 180 | Self-mutilation (HP:0000742) | 1.77844007 |
| 181 | Gait imbalance (HP:0002141) | 1.77539438 |
| 182 | Broad face (HP:0000283) | 1.75461824 |
| 183 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.72606737 |
| 184 | Meckel diverticulum (HP:0002245) | 1.72136119 |
| 185 | Abnormality of the ileum (HP:0001549) | 1.72065610 |
| 186 | Panhypogammaglobulinemia (HP:0003139) | 1.71605542 |
| 187 | Lymphoma (HP:0002665) | 1.71325367 |
| 188 | Rough bone trabeculation (HP:0100670) | 1.70779403 |
| 189 | Neutropenia (HP:0001875) | 1.70459604 |
| 190 | Hypoplasia of the pons (HP:0012110) | 1.70252394 |
| 191 | Febrile seizures (HP:0002373) | 1.69659560 |
| 192 | Cerebral hypomyelination (HP:0006808) | 1.68091027 |
| 193 | Macrocytic anemia (HP:0001972) | 1.68005372 |
| 194 | Abnormality of chromosome stability (HP:0003220) | 1.64925434 |
| 195 | Ragged-red muscle fibers (HP:0003200) | 1.64892539 |
| 196 | Poor head control (HP:0002421) | 1.63645281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.44062237 |
| 2 | STK16 | 4.40932916 |
| 3 | EIF2AK3 | 3.62318462 |
| 4 | RIPK4 | 3.47484236 |
| 5 | TNIK | 3.07318120 |
| 6 | CCNB1 | 3.03748923 |
| 7 | CDK19 | 2.85830997 |
| 8 | MAP3K12 | 2.80652112 |
| 9 | TYK2 | 2.78824850 |
| 10 | MAP3K14 | 2.74302982 |
| 11 | JAK1 | 2.46525755 |
| 12 | WEE1 | 2.41919533 |
| 13 | TAOK3 | 2.24176322 |
| 14 | MAP2K7 | 2.24026234 |
| 15 | IKBKE | 2.23225669 |
| 16 | ACVR1B | 2.19871268 |
| 17 | BUB1 | 2.18661490 |
| 18 | MAP3K13 | 2.11435585 |
| 19 | CSK | 2.04282380 |
| 20 | CAMKK2 | 2.01463959 |
| 21 | VRK1 | 2.00995922 |
| 22 | PIM2 | 1.98997039 |
| 23 | ITK | 1.97270823 |
| 24 | DAPK1 | 1.88072739 |
| 25 | TSSK6 | 1.85584107 |
| 26 | EIF2AK1 | 1.82309140 |
| 27 | IRAK3 | 1.73302682 |
| 28 | MKNK2 | 1.59465900 |
| 29 | FLT3 | 1.56135397 |
| 30 | ZAK | 1.55299655 |
| 31 | AKT3 | 1.54893488 |
| 32 | KIT | 1.54291883 |
| 33 | NME2 | 1.53159038 |
| 34 | FGFR3 | 1.51899871 |
| 35 | IRAK4 | 1.50528509 |
| 36 | MUSK | 1.49619589 |
| 37 | BMPR2 | 1.49364769 |
| 38 | HCK | 1.49355283 |
| 39 | LCK | 1.48995263 |
| 40 | BRSK2 | 1.46372651 |
| 41 | TGFBR2 | 1.43066669 |
| 42 | GRK6 | 1.40840661 |
| 43 | IKBKB | 1.39576085 |
| 44 | TEC | 1.37224274 |
| 45 | TBK1 | 1.34648261 |
| 46 | FGFR4 | 1.33872098 |
| 47 | ADRBK2 | 1.32116776 |
| 48 | BRAF | 1.28684991 |
| 49 | MAPKAPK3 | 1.27955410 |
| 50 | PLK4 | 1.25486991 |
| 51 | NEK9 | 1.23740746 |
| 52 | CDK8 | 1.21601813 |
| 53 | FGR | 1.18076489 |
| 54 | JAK2 | 1.17866931 |
| 55 | GRK7 | 1.12116281 |
| 56 | SRPK1 | 1.10746708 |
| 57 | MKNK1 | 1.07916185 |
| 58 | CAMKK1 | 1.05564650 |
| 59 | SCYL2 | 1.04232382 |
| 60 | TESK2 | 1.03646262 |
| 61 | TNK2 | 1.02614227 |
| 62 | DYRK3 | 1.01522447 |
| 63 | SIK3 | 1.01050180 |
| 64 | EIF2AK2 | 1.00022248 |
| 65 | MARK3 | 0.99807634 |
| 66 | CDK12 | 0.96679058 |
| 67 | BMPR1B | 0.93787438 |
| 68 | STK10 | 0.92591403 |
| 69 | CDC42BPA | 0.92376648 |
| 70 | MAPK7 | 0.92013563 |
| 71 | MYLK | 0.91473587 |
| 72 | BRSK1 | 0.91292985 |
| 73 | TRPM7 | 0.90276976 |
| 74 | CDK6 | 0.90190060 |
| 75 | PDK1 | 0.89340450 |
| 76 | ARAF | 0.89052055 |
| 77 | PRKCQ | 0.84803230 |
| 78 | NLK | 0.84553663 |
| 79 | BTK | 0.83683737 |
| 80 | KDR | 0.82730628 |
| 81 | NTRK3 | 0.82442799 |
| 82 | ATR | 0.81178525 |
| 83 | TAOK2 | 0.80682108 |
| 84 | MAP3K10 | 0.80068199 |
| 85 | CDC7 | 0.79853126 |
| 86 | PRPF4B | 0.79767241 |
| 87 | ERN1 | 0.79404193 |
| 88 | YES1 | 0.78698730 |
| 89 | CDK3 | 0.78356978 |
| 90 | TLK1 | 0.78351596 |
| 91 | HIPK2 | 0.77633000 |
| 92 | MARK2 | 0.77590595 |
| 93 | PIM1 | 0.76740678 |
| 94 | MAPK11 | 0.76237319 |
| 95 | FES | 0.76101836 |
| 96 | MAPK13 | 0.76100178 |
| 97 | MAPK12 | 0.75610489 |
| 98 | MELK | 0.75520946 |
| 99 | BCKDK | 0.75514286 |
| 100 | CHUK | 0.73037410 |
| 101 | TXK | 0.71361924 |
| 102 | MAP3K1 | 0.70713630 |
| 103 | EPHB1 | 0.68179325 |
| 104 | PDGFRB | 0.67698751 |
| 105 | ZAP70 | 0.67371296 |
| 106 | RPS6KB2 | 0.66309926 |
| 107 | MAP3K3 | 0.65980966 |
| 108 | SGK3 | 0.65104129 |
| 109 | IRAK1 | 0.64609074 |
| 110 | WNK1 | 0.64420917 |
| 111 | PLK1 | 0.62953493 |
| 112 | CDK4 | 0.59981447 |
| 113 | PTK2B | 0.59798704 |
| 114 | CSF1R | 0.59721678 |
| 115 | CAMK1 | 0.58920651 |
| 116 | CDK7 | 0.56597071 |
| 117 | PRKCI | 0.55330477 |
| 118 | SYK | 0.54860486 |
| 119 | NEK1 | 0.54805896 |
| 120 | TYRO3 | 0.54125339 |
| 121 | FYN | 0.53957621 |
| 122 | PASK | 0.53557684 |
| 123 | MAP3K7 | 0.53516632 |
| 124 | MOS | 0.53462620 |
| 125 | AURKA | 0.50651221 |
| 126 | MATK | 0.50195765 |
| 127 | MAP3K11 | 0.49887766 |
| 128 | JAK3 | 0.49119678 |
| 129 | CAMK1D | 0.48493518 |
| 130 | BRD4 | 0.48170634 |
| 131 | SIK2 | 0.47556667 |
| 132 | NME1 | 0.47344349 |
| 133 | RET | 0.46102918 |
| 134 | EGFR | 0.45627154 |
| 135 | PLK3 | 0.45462411 |
| 136 | MAPK15 | 0.45256864 |
| 137 | PRKCH | 0.45220117 |
| 138 | FRK | 0.45060474 |
| 139 | NEK6 | 0.44122774 |
| 140 | PDPK1 | 0.42786672 |
| 141 | MAP3K2 | 0.41601016 |
| 142 | TTN | 0.40695517 |
| 143 | CHEK2 | 0.40362122 |
| 144 | MAP4K1 | 0.39865472 |
| 145 | MAP2K3 | 0.39277006 |
| 146 | LYN | 0.38174392 |
| 147 | ABL1 | 0.38015102 |
| 148 | PRKD2 | 0.37092884 |
| 149 | CSNK2A1 | 0.35575781 |
| 150 | TESK1 | 0.35106108 |
| 151 | EPHA3 | 0.34431412 |
| 152 | BLK | 0.33745078 |
| 153 | AURKB | 0.33222903 |
| 154 | RPS6KA4 | 0.32988214 |
| 155 | TTK | 0.31767873 |
| 156 | STK24 | 0.31597491 |
| 157 | KSR2 | 0.31462328 |
| 158 | CAMK4 | 0.31255966 |
| 159 | PLK2 | 0.31070282 |
| 160 | MAP3K5 | 0.30958515 |
| 161 | PINK1 | 0.30443268 |
| 162 | WNK3 | 0.30089586 |
| 163 | RAF1 | 0.29556961 |
| 164 | MAP3K4 | 0.29164148 |
| 165 | PIK3CG | 0.27934937 |
| 166 | CSNK2A2 | 0.27584477 |
| 167 | MAP2K6 | 0.26673828 |
| 168 | SGK2 | 0.26551932 |
| 169 | DAPK3 | 0.26025361 |
| 170 | PRKCG | 0.25388121 |
| 171 | DYRK2 | 0.25148505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.41778052 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.76180774 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.41550317 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.13526289 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.03934062 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.83215875 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.80886921 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.69182217 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.64104632 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.61785278 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.61178390 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.53637408 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37973700 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.36442658 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.35052795 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20125819 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16002969 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.14652476 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 2.08945675 |
| 20 | Asthma_Homo sapiens_hsa05310 | 2.07808388 |
| 21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.05500784 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.03217460 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99789128 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.96553234 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86340827 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.86313230 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.84016807 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.76081604 |
| 29 | Purine metabolism_Homo sapiens_hsa00230 | 1.72331765 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64533450 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60651284 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.60424153 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59371149 |
| 34 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.57371534 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.54243948 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53931129 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.48164338 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.47569601 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46523615 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.45701462 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45637292 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44757262 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.42584276 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41686105 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.38543131 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.38454239 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36986685 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 1.36825753 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33292410 |
| 50 | Malaria_Homo sapiens_hsa05144 | 1.31014804 |
| 51 | Cell cycle_Homo sapiens_hsa04110 | 1.28475323 |
| 52 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.28057513 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.26888737 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26157746 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 1.24583076 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21616962 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20969983 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20413762 |
| 59 | Huntingtons disease_Homo sapiens_hsa05016 | 1.19888092 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18771280 |
| 61 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.15572873 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 1.13758038 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13227716 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00954564 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.99958134 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99276833 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97367710 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97136767 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96516901 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96442489 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95286870 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94114844 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93590171 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.93388469 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 0.91913839 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91620458 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.91564008 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91177830 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90893535 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90875312 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90650358 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.90383675 |
| 83 | Nicotine addiction_Homo sapiens_hsa05033 | 0.89378256 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88996557 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87827737 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81915379 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80766932 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80523370 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80277935 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80042374 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77786143 |
| 92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77584780 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76115171 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75473641 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73412291 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71363495 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70797093 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70705860 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70161882 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66245006 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66199223 |
| 102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65966885 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.65540635 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63995194 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.62765758 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61271529 |
| 107 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59277419 |
| 108 | Legionellosis_Homo sapiens_hsa05134 | 0.57955728 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57594267 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57391325 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57013070 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56881456 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56728649 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56724907 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56194731 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56070828 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55592405 |
| 118 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55383102 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54311044 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53938236 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53635342 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52970191 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52911499 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52527405 |
| 125 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.50786023 |
| 126 | Prostate cancer_Homo sapiens_hsa05215 | 0.50537996 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50333441 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.49648698 |
| 129 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49493804 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49192146 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48812951 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.47727329 |
| 133 | Measles_Homo sapiens_hsa05162 | 0.47681284 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47555887 |
| 135 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46677189 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.45713350 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44672852 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41279573 |
| 139 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40465378 |
| 140 | Shigellosis_Homo sapiens_hsa05131 | 0.40462043 |
| 141 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39794646 |
| 142 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39561454 |
| 143 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39329401 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.37883716 |
| 145 | Taste transduction_Homo sapiens_hsa04742 | 0.37666539 |
| 146 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36965367 |
| 147 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35517433 |
| 148 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34638946 |
| 149 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33890549 |
| 150 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33484055 |
| 151 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32993831 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32051715 |
| 153 | Alcoholism_Homo sapiens_hsa05034 | 0.31665298 |
| 154 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29124243 |
| 155 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28681594 |
| 156 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.28655813 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27917159 |
| 158 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27385885 |
| 159 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.27220897 |
| 160 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26982439 |
| 161 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.26351545 |
| 162 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.25650837 |
| 163 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.24916162 |
| 164 | Pertussis_Homo sapiens_hsa05133 | 0.24035201 |
| 165 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.23853489 |
| 166 | Morphine addiction_Homo sapiens_hsa05032 | 0.23328126 |
| 167 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23097198 |
| 168 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23018621 |
| 169 | Circadian entrainment_Homo sapiens_hsa04713 | 0.22761385 |
| 170 | Influenza A_Homo sapiens_hsa05164 | 0.22669196 |
| 171 | Allograft rejection_Homo sapiens_hsa05330 | 0.22546294 |
| 172 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19341812 |
| 173 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.18847560 |
| 174 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.18532352 |

